Literature DB >> 6347704

Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture.

J Le Bras, P Deloron, A Ricour, B Andrieu, J Savel, J P Coulaud.   

Abstract

Fifteen strains of Plasmodium falciparum have been cultivated since 1979 using the Trager and Jensen method of continuous culture on isolates from malaria patients. One hundred and two drug sensitivity studies have been carried out on these strains using a semimicro test. Three isolates, initially resistant to chloroquine, adapted rapidly to in vitro cultivation and maintained their high level of resistance (ED50 above 660 nM). Eleven isolates, initially chloroquine sensitive (ED50 under 90 nM) became resistant to this drug (ED50 = 190 to 1950 nM) after the 2-15 weeks required for their adaptation to continuous culture. The resistance of these strains never decreased during the following 15 months of continuous culture. The sensitivity to quinine varied initially from one strain to another (ED50 = 160 to 660 nM) and fluctuated during cultivation in the ratio of 1:3.5 for a given strain. The sensitivity of mefloquine remained high for all strains (ED50 under 150 nM) but one (ED50 = 560 nM). These results suggest that there might be a relationship between in vitro adaptation to culture of P. falciparum by the Trager-Jensen method and a chloroquine-resistant characteristic of the strain. There is the possibility of the emergence of a drug-resistant subpopulation or of changes in the metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347704     DOI: 10.1016/0014-4894(83)90091-7

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  10 in total

1.  Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.

Authors:  Stéphane Pelleau; Lionel Bertaux; Sébastien Briolant; Michael T Ferdig; Véronique Sinou; Bruno Pradines; Daniel Parzy; Ronan Jambou
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.

Authors:  P Druilhe; P Daubersies; J Patarapotikul; C Gentil; L Chene; T Chongsuphajaisiddhi; S Mellouk; G Langsley
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

3.  Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.

Authors:  Suwanna Chaorattanakawee; David L Saunders; Darapiseth Sea; Nitima Chanarat; Kritsanai Yingyuen; Siratchana Sundrakes; Piyaporn Saingam; Nillawan Buathong; Sabaithip Sriwichai; Soklyda Chann; Youry Se; You Yom; Thay Kheng Heng; Nareth Kong; Worachet Kuntawunginn; Kuntida Tangthongchaiwiriya; Christopher Jacob; Shannon Takala-Harrison; Christopher Plowe; Jessica T Lin; Char Meng Chuor; Satharath Prom; Stuart D Tyner; Panita Gosi; Paktiya Teja-Isavadharm; Chanthap Lon; Charlotte A Lanteri
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

4.  Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance.

Authors:  F Verdier; J Le Bras; F Clavier; I Hatin; M C Blayo
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

5.  Competition between Plasmodium falciparum strains in clinical infections during in vitro culture adaptation.

Authors:  Kexuan Chen; Ling Sun; Yingxue Lin; Qi Fan; Zhenjun Zhao; Mingming Hao; Guohua Feng; Yanrui Wu; Liwang Cui; Zhaoqing Yang
Journal:  Infect Genet Evol       Date:  2014-03-22       Impact factor: 3.342

6.  Cloning and heterologous expression of Plasmodium ovale dihydrofolate reductase-thymidylate synthase gene.

Authors:  Srisuda Tirakarn; Pinpunya Riangrungroj; Palangpon Kongsaeree; Mallika Imwong; Yongyuth Yuthavong; Ubolsree Leartsakulpanich
Journal:  Parasitol Int       Date:  2012-01-02       Impact factor: 2.230

7.  Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.

Authors:  Suwanna Chaorattanakawee; Charlotte A Lanteri; Siratchana Sundrakes; Kritsanai Yingyuen; Panita Gosi; Nitima Chanarat; Saowaluk Wongarunkochakorn; Nillawan Buathong; Soklyda Chann; Worachet Kuntawunginn; Montri Arsanok; Jessica T Lin; Jonathan J Juliano; Stuart D Tyner; Mengchuor Char; Chanthap Lon; David L Saunders
Journal:  Malar J       Date:  2015-12-02       Impact factor: 2.979

8.  Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.

Authors:  Suwanna Chaorattanakawee; Stuart D Tyner; Chanthap Lon; Kritsanai Yingyuen; Wiriya Ruttvisutinunt; Siratchana Sundrakes; Piyaporn Sai-gnam; Jacob D Johnson; Douglas S Walsh; David L Saunders; Charlotte A Lanteri
Journal:  Malar J       Date:  2013-07-12       Impact factor: 2.979

9.  Correlation of molecular markers, Pfmdr1-N86Y and Pfcrt-K76T, with in vitro chloroquine resistant Plasmodium falciparum, isolated in the malaria endemic states of Assam and Arunachal Pradesh, Northeast India.

Authors:  Sandeep Kumar Shrivastava; Ravi Kumar Gupta; Jagdish Mahanta; Mohan Lal Dubey
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

10.  Potent antiplasmodial extracts and fractions from Terminalia mantaly and Terminalia superba.

Authors:  Cedric D J Mbouna; Rufin M T Kouipou; Rodrigue Keumoe; Lauve R Y Tchokouaha; Patrick V T Fokou; Brice M T Tali; Dinkar Sahal; Fabrice F Boyom
Journal:  Malar J       Date:  2018-04-03       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.